Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
Cortical Myoclonus in Huntington's Disease
Movement Disorders 9:633-641, Thompson,P.D.,et al, 1994
Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Myoclonus in Adult Huntington's Disease
Ann Neurol 29:213-215, Vogel,C.M.,et al, 1991
Sensorineural Hearing Loss:A Reversible Effect of Valproic Acid
Neurol 40:1896-1898, Armon,C.,et al, 1990
Valproic Acid in the Treatment of Nonepileptic Myoclonus
Arch Neurol 39:448-449, Sotaniemi,K.,et al, 1982
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Postanoxic Action Myoclonus (Lance-Adams Syndrome) Responding to Valproate
Arch Neurol 36:44-45, Rollinson,R.D.,et al, 1979
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Post-anoxic Action Myoclonus:Improvement with Valproic Acid
NEJM 299:313, Fah,S., 1978